University of Minnesota Law School, Minneapolis
Stakeholder Engagement and Sustainability Committee
Mr. Hall is a professor of practice at the Law School and is Of Counsel to the law firm of Faegre Baker Daniels where he counsels clients in the area of drug and medical device regulation and corporate compliance matters. He also serves as CEO of MR3 Medical LLC, a start-up medical device company. He is a frequent speaker on FDA regulatory issues and compliance matters and has testified a number of times before Congressional committees.
Prior to his association with the University of Minnesota Law School, Professor Hall served in various capacities with Guidant Corporation including Senior Vice President and Deputy General Counsel—Litigation and Compliance and General Counsel of the Cardiac Rhythm Management group. During this time, Professor Hall also served as Special Counsel to the Guidant Board of Directors Compliance Committee and as Counsel to the Guidant Chief Compliance Officer. Prior to joining Guidant, he was with Eli Lilly, including serving as the head of Lilly’s worldwide environmental law group.
Professor Hall received his B.A. from Indiana University in 1974 and his J.D. from the University of Michigan where he was a Weymouth Kirkland Scholar. Professor Hall’s interests include FDA regulation, corporate compliance and governance, negotiations and the interface between corporate practice and the academic world.